effect of l-carnitine on gut bacteria toxicity γ-Butyrobetaine Is a Proatherogenic Intermediate in Microbial Metabolism to TMAO: Cell Metabolism γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PMC Diet gut microbiota interactions on cardiovascular disease ScienceDirect Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




